APA (7th ed.) Citation

Longato, E., Camillo, B. D., Sparacino, G., Tramontan, L., Avogaro, A., & Fadini, G. P. (2021). Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: A region-wide retrospective study. BMC.

Chicago Style (17th ed.) Citation

Longato, Enrico, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, and Gian Paolo Fadini. Cardiovascular Outcomes After Initiating GLP-1 Receptor Agonist or Basal Insulin for the Routine Treatment of Type 2 Diabetes: A Region-wide Retrospective Study. BMC, 2021.

MLA (8th ed.) Citation

Longato, Enrico, et al. Cardiovascular Outcomes After Initiating GLP-1 Receptor Agonist or Basal Insulin for the Routine Treatment of Type 2 Diabetes: A Region-wide Retrospective Study. BMC, 2021.